InClin, Inc.   Report issue

For profit Phase 2
Founded: San Mateo CA United States (1998)

Organization Overview

First Clinical Trial
2018
NCT03560271
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

InClin, Inc.